We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Trending > Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.
Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.
Trending

Starting later this week, some at-risk Americans become eligible for a 4th Covid shot.

Last updated: January 10, 2022 1:08 am
Editorial Board Published January 10, 2022
Share
SHARE
09virus briefing immuncompromised4thdose 01 facebookJumbo

Some people with a weakened immune system can get a fourth dose of the coronavirus vaccine as early as this coming week, according to recommendations from the Centers for Disease Control and Prevention that were updated last week.

The C.D.C. endorsed a third dose of the Pfizer-BioNTech and Moderna vaccines for moderately or severely immunocompromised people on Aug. 13, but said this would be considered a part of the primary immunization, not a booster shot.

In October, the agency said those immunocompromised people could receive a booster shot — a fourth dose of vaccine, six months after their third dose. These guidelines were consistent with its recommendation for other adults.

Last week, hoping to stem the surge of infections with the highly contagious Omicron variant, the C.D.C. shortened that interval to five months for a booster shot for Pfizer-BioNTech or Moderna recipients.

For immunocompromised people who received a single shot of the coronavirus vaccine made by Johnson & Johnson, the C.D.C. does not recommend additional primary doses, but advises that they get a booster shot of the Moderna or Pfizer-BioNTech vaccines two months after the first dose.

Some people are born with absent or faulty immune systems, and in others, treatments for some diseases like cancer diminish the potency of immune defenses. The C.D.C. estimates there are about seven million immunocompromised individuals in the country.

Many of them produce few to no antibodies in response to a vaccine or an infection, leaving them susceptible to the virus. When they do become infected, they may suffer prolonged illness, with death rates as high as 55 percent.

It is unclear what proportion of those people are protected by additional doses. Still, with the Omicron variant surging in the country, some immunocompromised people sought out fourth or even fifth shots of the vaccines even before the C.D.C. changed its guidelines. While receiving multiple doses of vaccines in a short period is unlikely to be harmful, it may produce diminishing returns, according to some experts.

The C.D.C. has said that any American 12 and older can receive a Pfizer-BioNTech booster — those 18 and older can alternatively receive a Moderna booster — five months after completing their initial shots with those vaccines. Israel has already begun offering fourth doses to high-risk groups including older adults. But the Biden administration has not yet said whether it plans to follow suit.

When asked on Friday about the possibility of a fourth shot for the general population, Dr. Rochelle Walensky, director of the C.D.C., said that focus remained on Americans eligible for their third shots.

She added that U.S. officials remained in close touch with Israel experts about their data. “We will be following our own data carefully as well, to see how these boosters are working in terms of waning effectiveness, not just for infection but, importantly, for severe disease,” she said.

You Might Also Like

“A Family’s Fight to Reclaim Their Legacy”

Streamline, Scale, Succeed: Why Global Enterprises Are Moving to Odoo ERP

Beloved Children’s Book 𝑻𝒉𝒆 𝑴𝒂𝒑 𝑴𝒚 𝑴𝒐𝒎𝒔 𝑮𝒂𝒗𝒆 𝑴𝒆 Returns to Best-Seller Status Years After Its Release — and Fans Are Begging for More

Model With a Mission: In Conversation With Maurice Giovanni

AI Architecture Pioneer: How Abdul Muqtadir Mohammed Is Reshaping Cloud, Code, and Supply Chains

TAGGED:BioNTech SECenters for Disease Control and PreventionCoronavirus (2019-nCoV)Coronavirus Omicron VariantImmune SystemModerna IncPfizer IncThe Washington MailUnited StatesVaccination and Immunization
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
For Three Avant-Garde Musicians, It’s Time for Pop
Entertainment

For Three Avant-Garde Musicians, It’s Time for Pop

Editorial Board February 11, 2022
Mayor Adams broadcasts new Workplace to Fight Antisemitism
Supreme Court docket permits reinstatement of Trump ban on transgender troops
Mindfulness course discovered to be efficient in folks with difficult-to-treat melancholy
The Final Home Looking Guidelines for Consumers

You Might Also Like

Global Security and Health Resilience: How AI-Driven Systems Could Reinvent National Safety—And the Visionary Behind the Shift
Trending

Global Security and Health Resilience: How AI-Driven Systems Could Reinvent National Safety—And the Visionary Behind the Shift

June 16, 2025
How AI Is Being Used to Enforce Modern Kleptocracy
TechnologyTrending

How AI Is Being Used to Enforce Modern Kleptocracy

June 16, 2025
We’ve Cracked the Code to Reality — And It Changes Everything
LifestyleTrending

We’ve Cracked the Code to Reality — And It Changes Everything

June 12, 2025
India Leads the World in Climate Action with Historic Tree Plantation Record
TrendingWorld

India Leads the World in Climate Action with Historic Tree Plantation Record

June 10, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?